⏳ Fetching live dividend data...
Home › Calculator › EARS Dividend Calculator 2026
Altamira Therapeutics Ltd. · NASDAQ
Price: $3.05 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in EARS → $1.56M in 10 years · $51,490.41/month
The company is dedicated to creating innovative therapeutic solutions for pressing medical requirements within neurotology and central nervous system disorders. Based in Zug, Switzerland, the firm operates with a modest team of 11 full-time employees. A significant part of its developmental pipeline focuses on intranasal betahistine, specifically AM-125 for addressing vertigo and AM-201 for mitigating antipsychotic-induced weight gain and somnolence. Both betahistine programs are currently in their initial Phase 1 clinical trial stage. Beyond these, the company's product portfolio includes several other promising candidates. Among them are AM-111, a brimapitide-based compound targeting acute inner ear hearing loss, and Keyzilen (AM-101), an eskatemine-based treatment for acute inner ear tinnitus; both are advanced to Phase 3 clinical trials. Additionally, AM-102, another potential treatment for tinnitus, is undergoing preclinical evaluation aimed at identifying the optimal lead compound. The company maintains its operational presence through subsidiary entities located in Switzerland, Ireland, and the United States.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open EARS position with:
Real after-tax yield depends on where you live and how you hold EARS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 65.68% | 62.88% | $6,568 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 55.83% | 53.03% | $5,583 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 52.54% | 49.74% | $5,254 / yr |
| 🇬🇧 UK ISA | 0% | 65.68% | 62.88% | $6,568 / yr |
| 🇬🇧 UK Taxable | 8.75% | 59.93% | 57.13% | $5,993 / yr |
| 🇨🇦 TFSA | 0% | 65.68% | 62.88% | $6,568 / yr |
| 🇨🇦 CA Taxable | 25% | 49.26% | 46.46% | $4,926 / yr |
| 🇦🇺 Super (pension) | 15% | 55.83% | 53.03% | $5,583 / yr |
| 🇦🇺 AU Taxable | 30% | 45.98% | 43.18% | $4,598 / yr |
| 🇩🇪 DE Taxable | 26.375% | 48.36% | 45.56% | $4,836 / yr |
| 🇫🇷 FR Taxable | 30% | 45.98% | 43.18% | $4,598 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
EARS pays quarterly — 4 times per year. Next ex-div: TBD.
How EARS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for EARS sourced from FMP /financial-growth endpoint — real data, not estimates.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the EARS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Altamira Therapeutics Ltd. (EARS) is currently trading at $3.05, 15% below its 52-week high. The current dividend yield is 65.68% based on an annual payout of $2.00 per share.
Altamira Therapeutics Ltd. (EARS) is a healthcare stock currently trading at $3.04 with a dividend yield of 65.68%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →